nortriptyline has been researched along with Acute Disease in 6 studies
Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The goal of the study was to describe with prospective methodology the therapeutic response to nortriptyline in the respiratory panic disorder (PD) subtype versus the non-respiratory subtype." | 7.72 | Respiratory panic disorder subtype: acute and long-term response to nortriptyline, a noradrenergic tricyclic antidepressant. ( Lopes, FL; Mezzasalma, MA; Nardi, AE; Nascimento, I; Valença, AM; Versiani, M; Zin, WA, 2003) |
| "Nortriptyline has been reported to be safe in porphyric patients." | 5.27 | Exacerbation of acute intermittent porphyria by nortriptyline. ( Krummel, SJ; Wesner, RB, 1986) |
| "The goal of the study was to describe with prospective methodology the therapeutic response to nortriptyline in the respiratory panic disorder (PD) subtype versus the non-respiratory subtype." | 3.72 | Respiratory panic disorder subtype: acute and long-term response to nortriptyline, a noradrenergic tricyclic antidepressant. ( Lopes, FL; Mezzasalma, MA; Nardi, AE; Nascimento, I; Valença, AM; Versiani, M; Zin, WA, 2003) |
| "Nortriptyline has been reported to be safe in porphyric patients." | 1.27 | Exacerbation of acute intermittent porphyria by nortriptyline. ( Krummel, SJ; Wesner, RB, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nardi, AE | 1 |
| Nascimento, I | 1 |
| Valença, AM | 1 |
| Lopes, FL | 1 |
| Mezzasalma, MA | 1 |
| Zin, WA | 1 |
| Versiani, M | 1 |
| Morse, JQ | 1 |
| Pilkonis, PA | 1 |
| Houck, PR | 1 |
| Frank, E | 1 |
| Reynolds, CF | 1 |
| Tune, L | 1 |
| Coyle, JT | 1 |
| Stokes, PE | 1 |
| Krummel, SJ | 1 |
| Wesner, RB | 1 |
| Rawlins, MD | 1 |
2 reviews available for nortriptyline and Acute Disease
| Article | Year |
|---|---|
A primary care perspective on management of acute and long-term depression.
Topics: Acute Disease; Adult; Aged; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combina | 1993 |
Variability in response to drugs.
Topics: Acute Disease; Acylation; Chlorthalidone; Chronic Disease; Depression; Diazoxide; Digoxin; Dose-Resp | 1974 |
1 trial available for nortriptyline and Acute Disease
| Article | Year |
|---|---|
Impact of cluster C personality disorders on outcomes of acute and maintenance treatment in late-life depression.
Topics: Activities of Daily Living; Acute Disease; Aged; Antidepressive Agents, Tricyclic; Cluster Analysis; | 2005 |
3 other studies available for nortriptyline and Acute Disease
| Article | Year |
|---|---|
Respiratory panic disorder subtype: acute and long-term response to nortriptyline, a noradrenergic tricyclic antidepressant.
Topics: Acute Disease; Adult; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Drug Admin | 2003 |
Acute extrapyramidal side effects: serum levels of neuroleptics and anticholinergics.
Topics: Acute Disease; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Chlorpromazi | 1981 |
Exacerbation of acute intermittent porphyria by nortriptyline.
Topics: Acute Disease; Adult; Humans; Hydrocephalus; Male; Nortriptyline; Porphyrias | 1986 |